Related Experiment Video

Updated: Jul 5, 2025

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
09:57

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

6.7K

Decoding the secrets: how conformational and structural regulators inhibit the human 20S proteasome

Pedro M P Fernandes1,2,3, Romina A Guedes1,2,3, Bruno L Victor4

  • 1Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.

Frontiers in Chemistry
|January 23, 2024
PubMed

Insights

Drug resistance in targeted therapies is a challenge. Computational analysis revealed that the Cys52Phe mutation in the human proteasome critically impacts drug binding, offering insights into resistance mechanisms.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Pharmacology

Background:

  • Acquired resistance to targeted therapies, particularly those affecting protein function like the human proteasome, poses a significant clinical challenge.
  • Predicting drug binding and resistance due to specific protein mutations is crucial for effective treatment strategies.

Purpose of the Study:

  • To computationally investigate the impact of specific mutations (Ala49Thr, Ala50Val, Cys52Phe) in the human proteasome active site.
  • To understand how these mutations affect protein stability and drug interactions, potentially leading to resistance.

Main Methods:

  • Utilized molecular dynamics simulations to analyze protein stability.
  • Employed molecular docking calculations to assess ligand binding affinity.
  • Focused on mutations within the active site of the human proteasome.

Main Results:

  • The Cys52Phe mutation was identified as critically impacting protein-ligand binding.
  • Assessed the effects of Ala49Thr and Ala50Val mutations on protein stability and drug interactions.
  • Provided insights into how specific mutations can alter drug efficacy.

Conclusions:

  • The Cys52Phe mutation significantly disrupts the binding of drugs to the human proteasome.
  • Findings offer valuable insights into mechanisms of proteasome inhibitor resistance.
  • Highlights the importance of computational methods in predicting drug resistance.
Keywords:
20S proteasome inhibitorsdrug resistancemolecular dockingmolecular dynamicsmutations

More Related Videos

Monitoring of Ubiquitin-proteasome Activity in Living Cells Using a Degron dgn-destabilized Green Fluorescent Protein GFP-based Reporter Protein10:25

Monitoring of Ubiquitin-proteasome Activity in Living Cells Using a Degron dgn-destabilized Green Fluorescent Protein GFP-based Reporter Protein

Published on: November 10, 2012

16.7K
Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

6.7K

Related Concept Videos

The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
757
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
841
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
910
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K